LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 225 participants.

Also called NCT04060914

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 225 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04060914
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04060914. Randomized; no masking; primary purpose treatment. Start 2019-08-30 (anticipated); primary completion 2020-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
Acronym
LOTIC
Condition
Antiplatelet Therapy
Intervention (Drug)
Ticagrelor 90mg
Intervention (Drug)
Ticagrelor 90mg/60mg
Intervention (Drug)
Clopidogrel 75mg
Lead sponsor
Beijing Anzhen Hospital (class: other)

Record details

Record id
cardio:ct-nct04060914
Content hash
2665ab8801bab3e52e713027d07add3cc211fe1882be7df27523bcdccdf64e33